DUSP6 and urinary bladder cancer: To further confirm whether DUSP6 mediates mitophagy in bladder cancer through the mTOR pathway, we pre-treated DUSP6 knockdown cells with medium containing 1.5 μM of mTOR agonist MHY1485 for 12 hours, and observed that the level of mitophagy was decreased (Figure 7E).